SCHEMBL496895

SCHEMBL496895

O=S(=O)(O)Cc1cccnc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 2/20 0.53
CYP1A2 P05177 2/20 0.48
CYP2D6 P10635 1/20 0.48
FDPS P14324 3/20 0.47
RECQL P46063 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CHRNA7 P36544 1/20 0.47
FES P07332 1/20 0.46
RET P07949 1/20 0.46
MARK3 P27448 1/20 0.46
TYK2 P29597 1/20 0.46
FLT4 P35916 1/20 0.46
SYK P43405 1/20 0.46
CLK2 P49760 1/20 0.46
CLK4 Q9HAZ1 1/20 0.46
TBXAS1 P24557 1/20 0.46
BTN3A1 O00481 1/20 0.46
PDE3A Q14432 1/20 0.46
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28239696 0.91 NAPRT (0.46) NAPRTCYP1A2CYP2D6FDPSRECQL
Piperazine SCHEMBL28279545 0.90 NAPRT (0.45) NAPRTCYP1A2CYP2D6FDPSRECQL
SCHEMBL27468836 0.83 CYP1A2 (0.52) NAPRTCYP1A2CYP2D6FDPSRECQL
SCHEMBL769818 0.81 CHRNA7 (0.53) NAPRTFDPSCHRNA7TBXAS1
SCHEMBL1457306 0.80 NAPRT (0.48) NAPRTCYP1A2CYP2D6FDPSRECQL
SCHEMBL4881403 0.80 CA2 (0.57) NAPRTCYP1A2CYP2D6RECQLCYP3A4
SCHEMBL1271313 0.80 NAPRT (0.48) NAPRTCYP1A2CYP2D6FDPSRECQL
Phenylmethanesulfonic Acid SCHEMBL3538486 0.80 CA1 (0.47) NAPRTKDM4EALDH1A1
SCHEMBL29493165 0.80 CA2 (0.57) NAPRTCYP1A2CYP2D6RECQLCYP3A4
SCHEMBL1271314 0.80 CHRNB2 (0.50) NAPRTCYP1A2CYP2D6CHRNA7TBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113390983-B Detection method for simultaneously determining 3 impurities in Voranolan fumarate 株洲千金药业股份有限公司 2022-06-07 CN claimed
CN-113390983-A Detection method for simultaneously determining 3 impurities in Voranolan fumarate 株洲千金药业股份有限公司 2021-09-14 CN claimed
EP-2578577-A1 Sulfonyl esters of tetrahydrocannabinol and derivatives thereof Albany Molecular Research, Inc. (US) 2013-04-10 EP claimed
US-7674922-B2 Process for production of delta-9-tetrahydrocannabinol ALBANY MOLECULAR RESEARCH, INC. (US) 2010-03-09 US claimed
EP-1928853-A2 PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL AMR Technology, Inc. (US) 2008-06-11 EP claimed
US-20070093665-A1 Process for production of delta-9- tetrahydrocannabinol AMR TECHNOLOGY, INC. (US) 2007-04-26 US claimed
WO-2007041167-A2 PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL AMR TECHNOLOGY, INC. (US) 2007-04-12 WO claimed
EP-0011460-B1 PEROXYGEN BLEACHING AND COMPOSITIONS THEREFOR FMC Corporation (US) 1982-09-29 EP claimed
WO-2023103898-A1 COMPOUND HAVING CLK AND DYRK INHIBITORY ACTIVITIES, PREPARATION METHOD THEREFOR AND USE THEREOF 赛诺哈勃药业(成都)有限公司 2023-06-15 WO disclosed
CN-113390983-B Detection method for simultaneously determining 3 impurities in Voranolan fumarate 株洲千金药业股份有限公司 2022-06-07 CN disclosed
CN-113390983-B Detection method for simultaneously determining 3 impurities in Voranolan fumarate 株洲千金药业股份有限公司 2022-06-07 CN disclosed
CN-113390983-A Detection method for simultaneously determining 3 impurities in Voranolan fumarate 株洲千金药业股份有限公司 2021-09-14 CN disclosed
CN-113390983-A Detection method for simultaneously determining 3 impurities in Voranolan fumarate 株洲千金药业股份有限公司 2021-09-14 CN disclosed
EP-2578577-A1 Sulfonyl esters of tetrahydrocannabinol and derivatives thereof Albany Molecular Research, Inc. (US) 2013-04-10 EP disclosed
US-20110263878-A1 PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL ALBANY MOLECULAR RESEARCH, INC. (US) 2011-10-27 US disclosed
US-20100069651-A1 PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL ALBANY MOLECULAR RESEARCH, INC. (US) 2010-03-18 US disclosed
US-7674922-B2 Process for production of delta-9-tetrahydrocannabinol ALBANY MOLECULAR RESEARCH, INC. (US) 2010-03-09 US disclosed
EP-1928853-A2 PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL AMR Technology, Inc. (US) 2008-06-11 EP disclosed
US-20070093665-A1 Process for production of delta-9- tetrahydrocannabinol AMR TECHNOLOGY, INC. (US) 2007-04-26 US disclosed
WO-2007041167-A2 PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL AMR TECHNOLOGY, INC. (US) 2007-04-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069651-A1 PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL CNR2, CNR1, HRH4 NAPRT 2260/4885CYP1A2 753/4885CYP2D6 638/4885
US-20070093665-A1 Process for production of delta-9- tetrahydrocannabinol CNR2, CNR1, HRH4 NAPRT 2260/4885CYP1A2 753/4885CYP2D6 638/4885
US-20110263878-A1 PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL CNR2, CNR1, HRH4 NAPRT 2260/4885CYP1A2 753/4885CYP2D6 638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.